Emergent News

January 5, 2026

Vaxess 2025 Year in Review

Vaxess

Featured Publications

April 9, 2025

Woburn biotech takes needles out of GLP-1 delivery with patch

Boston Business Journal

February 19, 2025

No more needles? Startups are testing patches to deliver weight-loss drugs and other medications

The Boston Globe

June 23, 2025

Vaxess study highlights GLP-1 delivery with microarray patch

Drug Delivery Business

Announcements

January 5, 2026

Vaxess 2025 Year in Review

Vaxess

December 4, 2025

Vaxess Human Factors Study Shows Patient Preference for Patch-Based GLP-1 Delivery Over Injections

Vaxess

September 17, 2025

Vaxess Announces Vice President of Manufacturing

Vaxess

June 23, 2025

Vaxess Presents Data on Development of Needle-Free, Self-Applied Microarray Patch for GLP-1 Delivery

Vaxess

April 9, 2025

Vaxess Announces $9M in Funding for Microarray Drug Delivery Platform

Vaxess

January 6, 2025

Vaxess 2024 Year in Review

Vaxess

October 1, 2024

Vaxess Receives National Institutes of Health Grant to Explore Administering Type 2 Diabetes Treatment via the MIMIX™ Transdermal Patch Platform

Vaxess

August 12, 2024

Vaxess Adds RA Capital Management Founding Partner Peter Kolchinsky to Board of Directors

Vaxess

May 22, 2024

Vaxess Announces $12M in Funding

Vaxess